320 related articles for article (PubMed ID: 34526059)
1. Comprehensive analysis of EMT-related genes and lncRNAs in the prognosis, immunity, and drug treatment of colorectal cancer.
Yang Y; Feng M; Bai L; Liao W; Zhou K; Zhang M; Wu Q; Wen F; Lei W; Zhang P; Zhang N; Huang J; Li Q
J Transl Med; 2021 Sep; 19(1):391. PubMed ID: 34526059
[TBL] [Abstract][Full Text] [Related]
2. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
4. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Autophagy-Related Genes and lncRNAs in Therapy and Prognosis of Colorectal Cancer.
Yang Y; Feng M; Bai L; Zhang M; Zhou K; Liao W; Lei W; Zhang N; Huang J; Li Q
Front Oncol; 2021; 11():582040. PubMed ID: 33777735
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
8. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
Yang ZD; Kang H
World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
10. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
12. A five-immune-related genes-based prognostic signature for colorectal cancer.
Zhu L; Wang H; Wang Z
Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
[TBL] [Abstract][Full Text] [Related]
13. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W
Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275
[TBL] [Abstract][Full Text] [Related]
14. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
Xu K; He J; Zhang J; Liu T; Yang F; Ren T
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
[TBL] [Abstract][Full Text] [Related]
17. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
18. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]